Sign outside of Regeneron Pharmaceuticals on Tuesday, Aug. 6, 2013 in East Greenbush, N.Y. The drug they make called Eylea has been highly successful so they are expanding.

Regeneron Pharmaceuticals, which employs 1,100 people at the University at Albany's East Campus, is looking to build a second complex nearby with labs, office space, a warehouse and manufacturing ...

EAST GREENBUSH — Regeneron Pharmaceuticals, Inc., the largest biopharmaceutical company in the state, plans to spend $70 million to expand its East Greenbush location and create 300 biotech jobs.

Hundreds of Regeneron employees volunteered to work weekends and put in long hours to make and test components of the kits, according to a company spokeswoman. Albany Business Review Select a City ...

Regeneron Pharmaceuticals Inc. will add 300 jobs to its drug-production operations in East Greenbush, the company and Gov. Andrew Cuomo announced Tuesday night.

North Greenbush Town Supervisor Joseph Bott says that commercial growth is up all over town. ... Located in East Greenbush, there’s also Regeneron’s role in attracting new residents.

EAST GREENBUSH — Regeneron said Tuesday that its experimental COVID-19 treatment has shown positive results in trials, with viral levels and severity of symptoms both reduced in non-hospitalized ...

TARRYTOWN, N.Y. >> Regeneron Pharmaceuticals, which has a production facility in East Greenbush, is expanding its Westchester County headquarters. Site preparation is underway for the erection of ...

You’d be forgiven for thinking the bustle of activity near Interstate 90’s Exit 9 in East Greenbush — where construction trailers form a long line close to the highway — has something to ...

Regeneron is planning a statewide expansion of its production facilities, including the final phase of its East Greenbush site. Regeneron plots $800M New York production push—along with 1,500 ...

EAST GREENBUSH, N. Y. (WRGB) - Regeneron plans to create 1,500 new full-time jobs in the greater Capital Region. The plan comes as Regeneron is set to invest approximately $800 million over seven ...